Alterity Therapeutics

Corporate Governance Statement 2024

Incentive Based Compensation Recovery Policy

Alterity Therapeutics Constitution (Amended November 2022)

Communication and Disclosure Policy 

Anti‐Bribery and Anti‐Corruption Policy

Securities Trading Policy

Board Charter

Whistle Blower Policy

Diversity Policy

2018 ADS Plan (as amended)

2004 ASX Plan (as amended)

Governance

<div class="ih-global-ui-overrides"></div>

<style>
  /* ==========================================================================
     InvestorHub Global UI Overrides
     Prefix: ih-
     Purpose:
       1) Hide share price / ticker widget
       2) Hide survey launcher button
       3) Hide injected timed survey popup panel
     ========================================================================== */

  /* --------------------------------------------------------------------------
     1) Hide ASX ticker / share price widget
     -------------------------------------------------------------------------- */
  #share-price {
    display: none !important;
    visibility: hidden !important;
    width: 0 !important;
    height: 0 !important;
    overflow: hidden !important;
  }

  #share-price + .h-8.w-px.bg-hubs-dividers {
    display: none !important;
  }

  /* --------------------------------------------------------------------------
     2) Hide the floating survey launcher button (bottom-right)
     (your earlier snippet)
     -------------------------------------------------------------------------- */
  .fixed.right-2.bottom-2.z-20.rounded-full.shadow-lg,
  .fixed.right-2.bottom-2.z-20 {
    display: none !important;
    visibility: hidden !important;
    pointer-events: none !important;
  }

  /* --------------------------------------------------------------------------
     3) Hide the timed/injected survey popup panel
     (the wrapper you pasted)
     -------------------------------------------------------------------------- */

  /* Extremely specific: matches the exact utility-class signature of that popup */
  .fixed.right-0.bottom-24.z-30.overflow-hidden.rounded-xl.shadow-xl.sm\:right-4.md\:bottom-4 {
    display: none !important;
    visibility: hidden !important;
    pointer-events: none !important;
  }

  /* Slightly more flexible fallback (in case spacing classes change later)
     Still specific enough to avoid collateral damage */
  .fixed.z-30.overflow-hidden.rounded-xl.shadow-xl.bottom-24 {
    display: none !important;
    visibility: hidden !important;
    pointer-events: none !important;
  }

  /* Optional: if it ever mounts but stays in DOM, ensure it can't capture clicks */
  .fixed.z-30.overflow-hidden.rounded-xl.shadow-xl.bottom-24 * {
    pointer-events: none !important;
  }
</style>

Contact Us

Events and Presentations

Investor Overview

Analyst Coverage

Share Price

Announcements

Press Releases [2025]

Investors

Home

ATH434

Multiple System Atrophy

Pipeline

Parkinsonian Diseases

The Science

Publications & Presentations

Team

About Us

About Us Overview

Montserrat

The Board of Directors of Alterity Therapeutics (the “Company”) sets high standards for the Company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company’s business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Date	Headline